274 related articles for article (PubMed ID: 6409443)
1. Tumor initiating activity of 9- and 10-fluoro-7,12-dimethylbenz[a]-anthracene (DMBA) and the effect of 2,3,7,8-tetrachlorodibenzo-p-dioxin on tumor initiation by monofluoro derivatives of DMBA in SENCAR mice.
DiGiovanni J; Decina PC; Diamond L
Carcinogenesis; 1983 Aug; 4(8):1045-9. PubMed ID: 6409443
[TBL] [Abstract][Full Text] [Related]
2. Tumor-initiating activity of 4-fluoro-7,12-dimethylbenz[a]anthracene and 1,2,3,4-tetrahydro-7,12-dimethylbenz[a]anthracene in female SENCAR mice.
DiGiovanni J; Diamond L; Singer JM; Daniel FB; Witiak DT; Slaga TJ
Carcinogenesis; 1982; 3(6):651-5. PubMed ID: 6811143
[TBL] [Abstract][Full Text] [Related]
3. Skin tumor initiating activities of the 9- and 10-fluoro derivatives of 7- or 12-methylbenz[a]anthracene and the 9- and 10-trifluoromethyl derivatives of 7,12-dimethylbenz[a]anthracene in SENCAR mice.
Sawyer TW; Fisher EP; DiGiovanni J
Carcinogenesis; 1987 Oct; 8(10):1465-8. PubMed ID: 3115616
[TBL] [Abstract][Full Text] [Related]
4. Mouse skin tumor-initiating activity of 5-, 7-, and 12-methyl- and fluorine-substituted benz[a]anthracenes.
Wood AW; Levin W; Chang RL; Conney AH; Slaga TJ; O'Malley RF; Newman MS; Buhler DR; Jerina DM
J Natl Cancer Inst; 1982 Sep; 69(3):725-8. PubMed ID: 6810009
[TBL] [Abstract][Full Text] [Related]
5. Correlation between formation of a specific hydrocarbon-deoxyribonucleoside adduct and tumor-initiating activity of 7,12-dimethylbenz(a)anthracene and its 9- and 10-monofluoroderivatives in mice.
DiGiovanni J; Sawyer TW; Fisher EP
Cancer Res; 1986 Sep; 46(9):4336-41. PubMed ID: 3089589
[TBL] [Abstract][Full Text] [Related]
6. Tumor-initiating activity and carcinogenicity of dibenzo[a,l]pyrene versus 7,12-dimethylbenz[a]anthracene and benzo[a]pyrene at low doses in mouse skin.
Higginbotham S; RamaKrishna NV; Johansson SL; Rogan EG; Cavalieri EL
Carcinogenesis; 1993 May; 14(5):875-8. PubMed ID: 8504480
[TBL] [Abstract][Full Text] [Related]
7. Evidence for a new model of tumor progression from carcinogenesis and tumor promotion studies with 7-bromomethylbenz[a]anthracene.
Scribner JD; Scribner NK; McKnight B; Mottet NK
Cancer Res; 1983 May; 43(5):2034-41. PubMed ID: 6403231
[TBL] [Abstract][Full Text] [Related]
8. Tumor progression in Sencar mouse skin as a function of initiator dose and promoter dose, duration, and type.
Ewing MW; Conti CJ; Kruszewski FH; Slaga TJ; DiGiovanni J
Cancer Res; 1988 Dec; 48(24 Pt 1):7048-54. PubMed ID: 3142681
[TBL] [Abstract][Full Text] [Related]
9. Potent tumor-initiating activity of the 3,4-dihydrodiol of 7,12-dimethylbenz(a)anthracene in mouse skin.
Slaga TJ; Gleason GL; DiGiovanni J; Sukumaran KB; Harvey RG
Cancer Res; 1979 Jun; 39(6 Pt 1):1934-6. PubMed ID: 109189
[TBL] [Abstract][Full Text] [Related]
10. Modulating effects of 2,3,7,8-tetrachlorodibenzo-p-dioxin on skin carcinogenesis initiated by the weak inducer 7,12-dimethylbenz(a)anthracene.
Lesca P; Perrot N; Peryt B
Drug Metabol Drug Interact; 1994; 11(1):37-57. PubMed ID: 12369593
[TBL] [Abstract][Full Text] [Related]
11. Effects of ellipticine, flavone, and 7,8-benzoflavone upon 7,12-dimethylbenz[a]anthracene, 7,14-dimethyldibenzo[a,h]anthracene and dibenzo[a,h]anthracene initiated skin tumors in mice.
Alworth WL; Slaga TJ
Carcinogenesis; 1985 Apr; 6(4):487-93. PubMed ID: 3921269
[TBL] [Abstract][Full Text] [Related]
12. A course of very small doses of DMBA, each of them allegedly with no promoting potency, acts with clear synergistic effect as a strong promoter of DMBA-initiated mouse skin carcinogenesis. A comparison of the tumorigenic and carcinogenic effects of DMBA (7,12-dimethylbenz-alpha-anthracene) and TPA (12-O-tetradecanoyl-phorbol-13-acetate) used as initiators and promoters in classical two-stage experimental protocols.
Iversen OH
APMIS Suppl; 1994; 41():1-38. PubMed ID: 7946481
[TBL] [Abstract][Full Text] [Related]
13. Comparative dose-response tumorigenicity studies of dibenzo[alpha,l]pyrene versus 7,12-dimethylbenz[alpha]anthracene, benzo[alpha]pyrene and two dibenzo[alpha,l]pyrene dihydrodiols in mouse skin and rat mammary gland.
Cavalieri EL; Higginbotham S; RamaKrishna NV; Devanesan PD; Todorovic R; Rogan EG; Salmasi S
Carcinogenesis; 1991 Oct; 12(10):1939-44. PubMed ID: 1934274
[TBL] [Abstract][Full Text] [Related]
14. Anticarcinogenic effects of 2,3,7,8-tetrachlorodibenzo-p-dioxin on benzo(a)pyrene and 7,12-dimethylbenz(a)anthracene tumor initiation and its relationship to DNA binding.
Cohen GM; Bracken WM; Iyer RP; Berry DL; Selkirk JK; Slaga TJ
Cancer Res; 1979 Oct; 39(10):4027-33. PubMed ID: 113085
[No Abstract] [Full Text] [Related]
15. Further investigations into the effect of non-benzo ring bay-region methyl substituents on tumor-initiating activity of polycyclic hydrocarbons.
Sawyer TW; Chang K; Harvey RG; DiGiovanni J
Cancer Lett; 1987 Sep; 36(3):317-24. PubMed ID: 3115560
[TBL] [Abstract][Full Text] [Related]
16. The importance of the "bay region" diol-epoxide in 7,12-dimethylbenz[a]anthracene skin tumor initiation and mutagenesis.
Slaga TJ; Huberman E; DiGiovanni J; Gleason G; Harvey RG
Cancer Lett; 1979 Apr; 6(4-5):213-20. PubMed ID: 108011
[TBL] [Abstract][Full Text] [Related]
17. FVB/N mice: an inbred strain sensitive to the chemical induction of squamous cell carcinomas in the skin.
Hennings H; Glick AB; Lowry DT; Krsmanovic LS; Sly LM; Yuspa SH
Carcinogenesis; 1993 Nov; 14(11):2353-8. PubMed ID: 8242866
[TBL] [Abstract][Full Text] [Related]
18. Inhibition of 7-bromomethylbenz[a]anthracene-promoted mouse skin tumor formation by retinoic acid and dexamethasone.
Verma AK; Garcia CT; Ashendel CL; Boutwell RK
Cancer Res; 1983 Jul; 43(7):3045-9. PubMed ID: 6406052
[TBL] [Abstract][Full Text] [Related]
19. Retinoic acid promotion of papilloma formation in mouse skin.
Hennings H; Wenk ML; Donahoe R
Cancer Lett; 1982; 16(1):1-5. PubMed ID: 6811129
[TBL] [Abstract][Full Text] [Related]
20. Covalent binding of 7,12-dimethylbenz(a)anthracene and 10-fluoro-7,12-dimethylbenz(a)anthracene to mouse epidermal DNA and its relationship to tumor-initiating activity.
DiGiovanni J; Fisher EP; Aalfs KK; Prichett WP
Cancer Res; 1985 Feb; 45(2):591-7. PubMed ID: 3917851
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
